Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.3M
-
Shares change
-
+952K
-
Total reported value, excl. options
-
$326K
-
Value change
-
+$216K
-
Number of buys
-
9
-
Number of sells
-
-3
-
Price
-
$0.25
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q4 2019
14 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q4 2019.
iBio, Inc. - Common Stock (IBIO) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.3M shares
.
Largest 10 shareholders include BlackRock Inc. (734K shares), CITADEL ADVISORS LLC (118K shares), VANGUARD GROUP INC (108K shares), Virtu Financial LLC (99.3K shares), UBS Group AG (98.5K shares), Creative Planning (34.4K shares), GEODE CAPITAL MANAGEMENT, LLC (34.3K shares), BARCLAYS PLC (30K shares), NORTHERN TRUST CORP (14.3K shares), and ExodusPoint Capital Management, LP (10.9K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.